Atlas Trials

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Clinical trial NCT02080689 · COMPLETED

Trial details

NCT number
NCT02080689
Sponsor
GenomeDx Biosciences Corp
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2014-05-01
Primary completion
2017-02-01
Enrollment
286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.